CDEK
← All organizations

Gabrail Cancer Center

Academic/HospitalWebsite ↗

Also known as: CEO, President, Gabrail Cancer Center | Gabrail Cancer Center Research

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Jan 1, 2007

Last known activity

Jul 18, 2023

Timeline

1990s

  1. Jan 1, 1990

    Gabrail Cancer Center— Founded

Drugs by trial phase (14 distinct, 12 trials)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (14)

  • NCT06056323CollaboratorPhase 1/Phase 2Jul 18, 2023
  • NCT05271292Overall official - principal investigatorPhase 1/Phase 2Aug 26, 2022
  • NCT04843709Overall official - principal investigatorPhase 1/Phase 2Jul 26, 2021
  • NCT04329728Overall official - principal investigatorPhase 1/Phase 2Jun 30, 2020
  • NCT04329728OfficialPhase 1/Phase 2Jun 30, 2020
  • NCT03797391Overall official - principal investigatorPhase 1/Phase 2Dec 13, 2018
  • NCT02856685Overall official - principal investigatorPhase 1/Phase 2Aug 1, 2016
  • NCT02310464Overall official - principal investigatorPhase 1Dec 1, 2015
  • NCT02250885Lead sponsorPhase 2Aug 1, 2014
  • NCT02250885Overall official - principal investigatorPhase 2Aug 1, 2014
  • NCT01678690Overall official - principal investigatorEarly Phase 1Aug 1, 2012
  • NCT00843050Overall official - principal investigatorPhase 2Nov 1, 2009
  • NCT00501735Overall official - principal investigatorPhase 2Jul 1, 2007
  • NCT00442598Overall official - principal investigatorPhase 2Jan 1, 2007

Details

Founded
Canton, OH, US Jan 1, 1990
Last known activity
Jul 18, 2023